Unanticipated side effects from treatment with high-dose mechlorethamine in patients with malignant melanoma
Hartmann, D.W.; Robinson, W.A.; Mangalik, A.; Glode, L.M.; Triebel, F.
Cancer Treatment Reports 65(3-4): 327-328
1981
ISSN/ISBN: 0361-5960 PMID: 7237455 Document Number: 172995
Document emailed within 1 workday
Related Documents
Karakousis, C.P.; Carlson, M. 1979: High-dose methotrexate in malignant melanoma Cancer Treatment Reports 63(8): 1405-1407Gorins, A. 1993: High-dose progestational contraception: side effects Contraception Fertilite Sexualite 21(2): 129-131
Jonasch, E.; Kumar, U.N.; Linette, G.P.; Hodi, F.S.; Soiffer, R.J.; Ryan, B.F.; Sober, A.J.; Mihm, M.C.; Tsao, H.; Langley, R.G.; Cosimi, B.A.; Gadd, M.A.; Tanabe, K.K.; Souba, W.; Haynes, H.A.; Barnhill, R.; Osteen, R.; Haluska, F.G. 2000: Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma Cancer Journal 6(3): 139-145
Neftel, K.A. 1985: Side effects of high-dose therapy with penicillins and cephalosporins Fortschritte der Medizin 103(38): 896-898
Van der Kuy, A.; Dansz, M. 1992: Severe psychological side effects in children due to use of high-dose deptropine Nederlands Tijdschrift Voor Geneeskunde 136(48): 2388-2389
Capizzi, R.L.; Powell, B.L. 1987: Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias Seminars in Oncology 14(2 Suppl 1: 40-50
Tamura, K.; Araki, Y.; Seita, M. 1984: Treatment for advanced malignant lymphoma in patients with compromised bone marrow--a combination therapy using pepleomycin, vincristine and high-dose adrenocorticoids (POP regimen) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(12 Part 1): 2568-2572
Schneider, W.; Bussmann, W.D.; Stahl, B.; Wietschoreck, A.; Kaltenbach, M. 1985: The antianginal efficacy of isosorbide dinitrate: dose-response relation and long-term effects of high-dose treatment Zeitschrift für Kardiologie 74(Suppl 1): 55-63
Marciani, M.G.; Cianciulli, P.; Stefani, N.; Stefanini, F.; Peroni, L.; Sabbadini, M.; Maschio, M.; Trua, G.; Papa, G. 1991: Toxic effects of high-dose deferoxamine treatment in patients with iron overload: an electrophysiological study of cerebral and visual function Haematologica 76(2): 131-134
Tsukada, Y.; Tauchi, K.; Nakamura, M.; Kishimoto, H.; Yoshifuku, S.; Otagiri, N.; Sasahara, K. 2010: Complete response achieved in a case of gastric gastrointestinal stromal tumor by administration of imatinib mesilate with concurrent relatively high-dose steroid therapy to control side effects Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(11): 2181-2184
Davis, J.C.; Fessler, B.J.; Tassiulas, I.O.; McInnes, I.B.; Yarboro, C.H.; Pillemer, S.; Wilder, R.; Fleisher, T.A.; Klippel, J.H.; Boumpas, D.T. 1998: High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis Journal of Rheumatology 25(9): 1694-1704
Miura, T.; Ishikawa, S. 1970: Malignant melanoma--synopses from the seminar on malignant melanoma by International Group for the Clinical Study of Melanoma Gan no Rinsho. Japan Journal of Cancer Clinics 16(11): 1064-1070
Grodd, W.; Schmiedl, U.; Hübener, K.H. 1986: Radiation treatment of malignant testicular tumors--results, side effects, analysis of recurrences Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 162(2): 79-87
Yaddanapudi, L.N.; Wig, J.; Singh, B.; Tewari, M.K. 2000: Comparison of efficacy and side effects of epidural tramadol and morphine in patients undergoing laminectomy: a repeated dose study Neurology India 48(4): 398-400
Chess, L.; Bock, G.N.; Ungaro, P.C.; Buchholz, D.H.; Mardiney, M.R. 1973: Immunologic effects of BCG in patients with malignant melanoma: specific evidence for stimulation of the 'secondary' immune response Journal of the National Cancer Institute 51(1): 57-65
Lissoni, P.; Brivio, F.; Brivio, O.; Fumagalli, L.; Gramazio, F.; Rossi, M.; Emanuelli, G.; Alderi, G.; Lavorato, F. 1995: Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients Journal of Biological Regulators and Homeostatic Agents 9(1): 31-33
Tsai, M-Chang.; Huang, T-Lai. 2010: Severe neuroleptic malignant syndrome: successful treatment with high-dose lorazepam and diazepam: a case report Chang Gung Medical Journal 33(5): 576-580
Seebacher, C.; Steinert, W.; Küster, P.; Koch, R. 1990: Results of treatment of malignant melanoma--a computer analysis of 772 patients Dermatologische Monatschrift 176(5-6): 337-344
Pander Maat, H.; Klaassen, R. 1996: The effect of the wording of information about side effects on patients' interpretation of reported side effects Nederlands Tijdschrift Voor Geneeskunde 140(8): 424-427
Hochster, H.; Levin, M.; Speyer, J.; Dunleavy, S.; Harris, M.; Roses, D.; Golomb, F.; Muggia, F. 1985: Single-dose dacarbazine and dactinomycin in advanced malignant melanoma Cancer Treatment Reports 69(1): 39-42